These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21178437)

  • 1. Chronic immune activation in the T cell compartment of HCV/HIV-1 co-infected patients.
    Sandberg JK; Falconer K; Gonzalez VD
    Virulence; 2010; 1(3):177-9. PubMed ID: 21178437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.
    Gonzalez VD; Falconer K; Blom KG; Reichard O; Mørn B; Laursen AL; Weis N; Alaeus A; Sandberg JK
    J Virol; 2009 Nov; 83(21):11407-11. PubMed ID: 19710147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
    J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor excision circles (TRECs), CD4+, CD8+, and their CD45RO+, and CD45RA+, subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy.
    Arizcorreta A; Márquez M; Fernández-Gutiérrez C; Guzmán EP; Brun F; Rodríguez-Iglesias M; Girón-González JA
    Clin Exp Immunol; 2006 Nov; 146(2):270-7. PubMed ID: 17034579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication.
    Ciuffreda D; Comte D; Cavassini M; Giostra E; Bühler L; Perruchoud M; Heim MH; Battegay M; Genné D; Mulhaupt B; Malinverni R; Oneta C; Bernasconi E; Monnat M; Cerny A; Chuard C; Borovicka J; Mentha G; Pascual M; Gonvers JJ; Pantaleo G; Dutoit V
    Eur J Immunol; 2008 Oct; 38(10):2665-77. PubMed ID: 18958874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
    Rohrbach J; Robinson N; Harcourt G; Hammond E; Gaudieri S; Gorgievski M; Telenti A; Keiser O; Günthard HF; Hirschel B; Hoffmann M; Bernasconi E; Battegay M; Furrer H; Klenerman P; Rauch A;
    Gut; 2010 Sep; 59(9):1252-8. PubMed ID: 20660698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection.
    Vrolijk JM; Kwekkeboom J; Janssen HL; Hansen BE; Zondervan PE; Osterhaus AD; Schalm SW; Haagmans BL
    J Infect Dis; 2003 Nov; 188(10):1528-32. PubMed ID: 14624378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of proliferation and differentiation of CD8+ T cells on the progression in patients co-infected with HIV and HCV].
    Zhang YH; Zhao Y; Ma LN; Shi LX; Jin Y; He ZM; Zhang XD; Chen XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):331-3. PubMed ID: 20387477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy.
    Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.
    Gonzalez VD; Falconer K; Michaëlsson J; Moll M; Reichard O; Alaeus A; Sandberg JK
    Clin Immunol; 2008 Jul; 128(1):46-56. PubMed ID: 18495540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T lymphocyte proliferative responses to hepatitis C virus (HCV) antigens in patients coinfected with HCV and human immunodeficiency virus who responded to anti-HCV treatment.
    Legrand E; Neau D; Galperine T; Trimoulet P; Moreau JF; Pitard V; Lacut JY; Ragnaud JM; Dupon M; Le Bail B; Bernard N; Schvoerer E; Houghton M; Fleury H; Lafon ME
    J Infect Dis; 2002 Aug; 186(3):302-11. PubMed ID: 12134226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection.
    Fan Z; Huang XL; Kalinski P; Young S; Rinaldo CR
    Clin Vaccine Immunol; 2007 Sep; 14(9):1127-37. PubMed ID: 17634507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Living donor liver transplantation in a patient with HIV].
    Sugawara Y; Makuuchi M; Morisawa Y; Kimura S; Tachikawa N; Oka S
    Nihon Rinsho; 2002 Apr; 60(4):803-6. PubMed ID: 11968792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.
    Chalupa P; Davidová A; Beran O; Arientová S; Boštík P; Kapla J; Kondělková K; Plíšek S; Holub M
    APMIS; 2016 Aug; 124(8):711-8. PubMed ID: 27307383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection.
    Alatrakchi N; Di Martino V; Thibault V; Benhamou Y; Katlama C; Poynard T; Autran B
    AIDS; 2004 Jan; 18(1):121-3. PubMed ID: 15090839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.